Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCT
3176
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $175K | ﹤0.01% |
16,360
+695
| +4% | +$5.01K |
|
3177
Armata Pharmaceuticals
ARMP
$173M
| $174K | ﹤0.01% |
53,596
-3,900
| -7% | -$9.21K |
|
|
GOCO
3178
DELISTED
GoHealth
GOCO
| $174K | ﹤0.01% |
13,072
-800
| -6% | -$10.9K |
|
3179
Microbot Medical
MBOT
$121M
| $174K | ﹤0.01% |
105,995
-17,599
| -14% | -$23.4K |
|
|
NOTV
3180
DELISTED
Inotiv
NOTV
| $174K | ﹤0.01% |
47,464
-7,100
| -13% | -$17.9K |
|
|
JT
3181
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
| $174K | ﹤0.01% |
177,069
-6,300
| -3% | -$6.18K |
|
3182
Cardiff Oncology
CRDF
$74.7M
| $172K | ﹤0.01% |
116,400
-37,600
| -24% | -$45.5K |
|
3183
Enlivex Ltd
ENLV
$33.3M
| $168K | ﹤0.01% |
4,139
+213
| +5% | +$5.43K |
|
3184
GEN Restaurant Group
GENK
$11.1M
| $168K | ﹤0.01% |
+21,500
| New | +$183K |
|
|
TTSH
3185
DELISTED
Tile Shop Holdings
TTSH
| $168K | ﹤0.01% |
22,800
+10,100
| +80% | +$60.8K |
|
3186
Barnes & Noble Education
BNED
$438M
| $167K | ﹤0.01% |
+1,123
| New | +$125K |
|
|
IOBT
3187
DELISTED
IO Biotech
IOBT
| $167K | ﹤0.01% |
88,900
+64,514
| +265% | +$76.9K |
|
3188
Imperial Petroleum
IMPP
$210M
| $166K | ﹤0.01% |
+62,800
| New | +$115K |
|
|
SLI
3189
Standard Lithium
SLI
$559M
| $166K | ﹤0.01% |
+82,145
| New | +$205K |
|
3190
Biote Corp
BTMD
$49.4M
| $165K | ﹤0.01% |
33,477
+4,900
| +17% | +$25.3K |
|
3191
Ovid Therapeutics
OVID
$495M
| $165K | ﹤0.01% |
51,200
-29,600
| -37% | -$101K |
|
|
SOHO
3192
DELISTED
Sotherly Hotels
SOHO
| $165K | ﹤0.01% |
110,814
-12,898
| -10% | -$20K |
|
3193
Lineage Cell Therapeutics
LCTX
$282M
| $164K | ﹤0.01% |
150,000
+90,300
| +151% | +$98.9K |
|
|
DHC
3194
Diversified Healthcare Trust
DHC
$2.11B
| $163K | ﹤0.01% |
43,636
+20,736
| +91% | +$48.8K |
|
|
GVP
3195
DELISTED
GSE Systems, Inc.
GVP
| $163K | ﹤0.01% |
81,309
+2,882
| +4% | +$7.82K |
|
3196
Katapult Holdings
KPLT
$32.1M
| $162K | ﹤0.01% |
14,904
+1,107
| +8% | +$11.6K |
|
3197
Key Tronic
KTCC
$44.7M
| $161K | ﹤0.01% |
37,300
+12,705
| +52% | +$51.9K |
|
|
EPIX
3198
DELISTED
ESSA Pharma
EPIX
| $160K | ﹤0.01% |
+24,234
| New | +$119K |
|
3199
Scienjoy Holding
SJ
$38.7M
| $160K | ﹤0.01% |
45,904
-4,396
| -9% | -$12.4K |
|
|
STRR
3200
DELISTED
Star Equity Holdings
STRR
| $160K | ﹤0.01% |
30,640
+340
| +1% | +$1.69K |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.